Pseudotumor cerebri classification: Difference between revisions

	Pseudotumor cerebri Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating pseudotumor cerebri from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pseudotumor cerebri classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pseudotumor cerebri classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pseudotumor cerebri classification
CDC on Pseudotumor cerebri classification
Pseudotumor cerebri classification in the news
Blogs on Pseudotumor cerebri classification
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Pseudotumor cerebri classification

VisualWikitext

Latest revision as of 12:35, 6 August 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Classification/Staging

According to the Frisen staging, there are 6 stages of IIH based on the ophthalmoscopic signs:

stage 0

Optic disc is normal but nasal and temporal disc borders are blurred.

stage 1

Increased blurring of the nasal border of optic disc but normal temporal margins.

stage 2

Changes are increase in proportion to stage 1 with elevation of nasal nerve head and temporal border blurring.

stage 3

Changes are increase in proportion to stage 2 with elevation of both nasal and temporal disc border and increased diameter of nerve head.

stage 4

Changes are increase in proportion to stage 3 with nerve head elevation and decreased nerve cup.

stage 5

Increased anterior expansion of nerve head which becomes smooth with dome-shaped appearance.^[1]

References

↑ Frisén L (January 1982). "Swelling of the optic nerve head: a staging scheme". J. Neurol. Neurosurg. Psychiatry. 45 (1): 13–8. PMC 491259. PMID 7062066.

Template:WH Template:WS

[pmid7062066-1] Frisén L (January 1982). "Swelling of the optic nerve head: a staging scheme". J. Neurol. Neurosurg. Psychiatry. 45 (1): 13–8. PMC 491259. PMID 7062066.

[1]

@@ Line 4: / Line 4: @@
 {{CMG}}; {{AE}}
 ==Overview==
-There is no established system for the classification of [disease name].
+==Classification/Staging==
-OR
+According to the Frisen staging, there are 6 stages of IIH based on the [[Ophthalmoscopy|ophthalmoscopic]] [[signs]]:
-[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
+===== stage 0 =====
+[[Optic disc]] is normal but [[nasal]] and [[temporal]] disc borders are blurred.
-OR
+===== stage 1 =====
+Increased blurring of the [[nasal]] border of [[optic disc]] but normal [[temporal]] margins.
-[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
+===== stage 2 =====
-[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
+Changes are increase in proportion to stage 1 with elevation of [[nasal]] [[nerve head]] and [[temporal]] border blurring.
-OR
+===== stage 3 =====
+Changes are increase in proportion to stage 2 with elevation of both [[nasal]] and [[temporal]] [[Optic disc|disc]] border and increased diameter of [[nerve head]].
-Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
+===== stage 4 =====
+Changes are increase in proportion to stage 3 with [[nerve head]] elevation and decreased nerve cup.
-OR
+===== stage 5 =====
+Increased anterior expansion of [[nerve head]] which becomes smooth with dome-shaped appearance.<ref name="pmid7062066">{{cite journal |vauthors=Frisén L |title=Swelling of the optic nerve head: a staging scheme |journal=J. Neurol. Neurosurg. Psychiatry |volume=45 |issue=1 |pages=13–8 |date=January 1982 |pmid=7062066 |pmc=491259 |doi= |url=}}</ref>
-If the staging system involves specific and characteristic findings and features:
-According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
-OR
-The staging of [malignancy name] is based on the [staging system].
-OR
-There is no established system for the staging of [malignancy name].
-==Classification==
-There is no established system for the classification of [disease name].
-OR
-[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
-*[Group1]
-*[Group2]
-*[Group3]
-*[Group4]
-OR
-[Disease name] may be classified into [large number > 6] subtypes based on:
-*[Classification method 1]
-*[Classification method 2]
-*[Classification method 3]
-[Disease name] may be classified into several subtypes based on:
-*[Classification method 1]
-*[Classification method 2]
-*[Classification method 3]
-OR
-Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
-OR
-'''If the staging system involves specific and characteristic findings and features:'''
-According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
-OR
-The staging of [malignancy name] is based on the [staging system].
-OR
-There is no established system for the staging of [malignancy name].
 ==References==